Concepedia

Author

Matthew Nitzahn

University of California, Los AngelesORCID

Also Known As

M. Nitzahn, Matt Nitzahn, Matthew Nitzahn, Nitzahn, Matthew

13

Publications

183

Citations

8

H-Index

14

Concepts

All Affiliations

University of California, Los AngelesUniversity Children's Hospital ZurichTelethon Institute Of Genetics And MedicineBaylor College of MedicineUniversity of California, Davis
MN

About

Matthew Nitzahn is an author at University of California, Los Angeles specializing in oxidative stress, metabolism, and medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

40

2

Biochemistry

2

2

40

3

Hepatology

2

2

40

4

Allergy

1

1

17

5

Immunology

1

1

17

Matthew Nitzahn

×

7

Publications

129

Citations

7

H-Index

YearCitations

Conditional disruption of hepatic carbamoyl phosphate synthetase 1 in mice results in hyperammonemia without orotic aciduria and can be corrected by liver-directed gene therapy

Suhail Khoja, Matthew Nitzahn, Kip Hermann,

Molecular Genetics and Metabolism

2018

23

Intermittent lipid nanoparticle mRNA administration prevents cortical dysmyelination associated with arginase deficiency

Suhail Khoja, Xiao-Bo Liu, Brian Truong,

Molecular Therapy — Nucleic Acids

2022

23

O-GlcNAcylation enhances CPS1 catalytic efficiency for ammonia and promotes ureagenesis

Leandro R. Soria, Georgios Makris, A. D’Alessio,

Nature Communications

2022

21

Hepatic glutamine synthetase augmentation enhances ammonia detoxification

Leandro R. Soria, Matthew Nitzahn, Angela De Angelis,

Journal of Inherited Metabolic Disease

2019

17

Split AAV-Mediated Gene Therapy Restores Ureagenesis in a Murine Model of Carbamoyl Phosphate Synthetase 1 Deficiency

Matthew Nitzahn, Gabriella Allegri, Suhail Khoja,

Molecular Therapy

2020

17

A constitutive knockout of murine carbamoyl phosphate synthetase 1 results in death with marked hyperglutaminemia and hyperammonemia

Suhail Khoja, Matthew Nitzahn, Brian Truong,

Journal of Inherited Metabolic Disease

2019

15

Gene therapy for guanidinoacetate methyltransferase deficiency restores cerebral and myocardial creatine while resolving behavioral abnormalities

Suhail Khoja, Jenna Lambert, Matthew Nitzahn,

Molecular Therapy — Methods & Clinical Development

2022

13

Page 1